Prostate Cancer
PCA: Prostate cancer, patient-centred approach or both? - Abstract
February 3, 2012
GU Cancers Symposium 2012 - Approved agents and related trials - Session Highlights
February 3, 2012
GU Cancers Symposium 2012 - Sequencing of therapies in men with castration-resistant prostate cancer - Session Highlights
February 3, 2012
GU Cancers Symposium 2012 - Castration-resistant prostate cancer: Novel targets, agents, and trials - Session Highlights
February 3, 2012
Myriad’s Prolaris® test shown to significantly predict biochemical recurrence risk after prostatectomy
February 3, 2012
GU Cancers Symposium 2012 - Role of dose escalation and supplemental androgen deprivation - Session Highlights
February 3, 2012
Intra-fraction motion during extreme hypofractionated radiotherapy of the prostate using pre- and post-treatment imaging - Abstract
February 2, 2012
The COMPASs Study: Community Preferences for Prostate cAncer Screening. Protocol for a quantitative preference study - Abstract
February 2, 2012
Frequency and determinants of disagreement and error in Gleason scores: A population-based study of prostate cancer - Abstract
February 2, 2012
Body mass index and incidence of localized and advanced prostate cancer--a dose-response meta-analysis of prospective studies - Abstract
February 2, 2012
Diagnostic performance of malignant prostatic cells detection in blood for early detection of prostate cancer: Comparison to prostatic biopsy - Abstract
February 2, 2012
Dynamic contrast-enhanced MR imaging findings of bone metastasis in patients with prostate cancer - Abstract
February 2, 2012